Validation of MMS Test for Cancer Monitoring

Validation of MMS Test to Detect Active Tumor Growth of Different Cancer Types Before and After Therapy, as Well as for Subsequent Relapse Control in Comparison to Conventional Methods

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02113683

Acronym

MMS-TM

Enrollment

100

Registered

2014-04-15

Start date

2014-05-31

Completion date

2018-06-20

Last updated

2018-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colo-rectal Cancer, Melanoma, Sarcoma, Stomach Cancer

Keywords

colo-rectal cancer, stomach cancer, melanoma, MMS test, therapy monitoring, Sarcoma

Brief summary

The purpose of this study is the validation of MMS test to detect active tumor growth in different cancer types before and after therapy, as well as in the course of therapy and for subsequent relapse control compared to standard methods (clinical examination, imaging, tumor markers). It should be consider whether the MMS test has comparable diagnostic accuracy, and thus can replace more expensive or invasive procedures in future.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Clinical diagnosis of colo-rectal cancer * Clinical diagnosis of stomach cancer * Suspected diagnosis of melanoma

Exclusion criteria

* Colitis ulcerosa * Morbus Crohn * Cancer in time period two years before * Cancer therapy in time period two years before

Design outcomes

Primary

Measure	Time frame
active tumor growth before and after cancer therapy	up to 36 month

Countries

Germany

Outcome results